Grant funds totaling $1.5 million are available in fiscal year 2009 to support the Clinical Trials Transformation Initiative for researchers to improve the design and execution of clinical trials. The systematic modernization of the clinical trial process is a goal shared by both the Clinical Trials Transformation Initiative, started by the FDA and Duke University's Department of Transitional Medicine, as well as the Critical Path Initiative, which was launched by the FDA in 2004 to help modernize the development, evaluation, manufacture and use of FDA-regulated products. FDA Notice, ¶43,790.
For more information on this and related topics, consult the CCHFDA Food, Drug and Cosmetic Law Reporter.
Visit our News Library to read more news stories.
Food, Drug and Cosmetics Law Reporter
Everything you need to know about Food and Drug Regulations.Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Learn More » |
Medical Devices ReporterAccess the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices. Learn More »
|
